Vanflita tablets 17.7mg, containing Quizartinib hydrochloride, are manufactured by Daiichi Sankyo. This medication (YJ code: 4291060F1021, 17.7 mg 1 tablet) is a kinase inhibitor generally used to treat specific forms of acute myeloid leukemia (AML).
Vanflita tablets 17.7mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →